Title : Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial.

Pub. Date : 2022 Feb

PMID : 33855585






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial. Sorafenib interleukin 6 Homo sapiens
2 CONCLUSION: IL-6 and IL-8 baseline values predicted outcomes of sorafenib-treated patients in this well-characterized prospective cohort of the SORAMIC trial. Sorafenib interleukin 6 Homo sapiens